Syndromic Surveillance for COVID-19, Massachusetts, February 2020–November 2022: The Impact of Fever and Severity on Algorithm Performance

Author:

Cocoros Noelle M.1ORCID,Willis Sarah J.12,Eberhardt Karen3,Morrison Monica4,Randall Liisa M.4,DeMaria Alfred4,Brown Catherine M.4,Madoff Lawrence C.4,Zambarano Bob3,Sljivo Selsebil1,Nagavedu Kshema1,Klompas Michael15

Affiliation:

1. Harvard Pilgrim Health Care Institute, Boston, MA, USA

2. Now with Pfizer, New York, NY, USA

3. Commonwealth Informatics, Waltham, MA, USA

4. Massachusetts Department of Public Health, Boston, MA, USA

5. Brigham and Women’s Hospital, Boston, MA, USA

Abstract

Objectives: Syndromic surveillance can help identify the onset, location, affected populations, and trends in infectious diseases quickly and efficiently. We developed an electronic medical record–based surveillance algorithm for COVID-19–like illness (CLI) and assessed its performance in 5 Massachusetts medical practice groups compared with statewide counts of confirmed cases. Materials and Methods: Using data from February 2020 through November 2022, the CLI algorithm was implemented in sites that provide ambulatory and inpatient care for about 25% of the state. The initial algorithm for CLI was modeled on influenza-like illness: an International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis code for COVID-19 and an ICD-10-CM diagnosis code suggesting severe lower respiratory tract infection or ≥1 ICD-10-CM diagnosis code for upper or lower respiratory tract infection plus fever. We generated weekly counts of CLI cases and patients with ≥1 clinical encounter and visually compared trends with those of statewide laboratory-confirmed cases. Results: The initial algorithm tracked well with the spring 2020 wave of COVID-19, but the components that required fever did not clearly detect the November 2020–January 2021 surge and identified <1% of weekly encounters as CLI. We revised the algorithm by adding more mild symptoms and removing the fever requirement; this revision improved alignment with statewide confirmed cases through spring 2022 and increased the proportion of encounters identified as CLI to about 2% to 6% weekly. Alignment between CLI trends and confirmed COVID-19 case counts diverged again in fall 2022, likely because of decreased COVID-19 testing and increases in other respiratory viruses. Practice Implications: Our work highlights the importance of using a broad definition for COVID-19 syndromic surveillance and the need for surveillance systems that are flexible and adaptable to changing trends and patterns in disease or care.

Funder

Massachusetts Department of Public Health

Publisher

SAGE Publications

Subject

Public Health, Environmental and Occupational Health

Reference24 articles.

1. Centers for Disease Control and Prevention. International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). Published October 17, 2022. Accessed May 5, 2023. https://www.cdc.gov/nchs/icd/icd-10-cm.htm

2. Implementing Syndromic Surveillance: A Practical Guide Informed by the Early Experience

3. Centers for Disease Control and Prevention. Overview of the National Syndromic Surveillance Program. 2022. Accessed August 9, 2022. https://www.cdc.gov/nssp/documents/NSSP-overview.pdf

4. Centers for Disease Control and Prevention. US influenza surveillance: purpose and methods. Published January 21, 2022. Accessed August 9, 2022. https://www.cdc.gov/flu/weekly/overview.htm

5. Integrating Clinical Practice and Public Health Surveillance Using Electronic Medical Record Systems

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3